Research interest: Tumor pathology and
therapy, comparative pathology, neuroinfectiology and neurodegenerative
diseases, virus discovery
Kerstin Hahn studied veterinary medicine at the University of Hannover (Germany), where she graduated in 2010.
After graduation, she started a combined Residency/PhD program at the Department of Pathology at the University of Veterinary Medicine Hannover.
She pursued several research projects in the group of Prof. Baumgärtner focusing on neuro-infectiology and neurodegenerative diseases including gene therapy. Thereby, she was involved in the generation and histological evaluation of mouse models.
She further pursued several projects aiming on the characterization of emerging viral diseases in a variety of animal species using deep-sequencing and in situ-hybridization.
Her pathology residency training included an industry sponsored toxicologic pathology modular training program over 2 years counting 16 modules. She earned her Veterinary Doctoral Degree and her PhD in 2015.
In May 2015, Kerstin Hahn joined the Institute of Animal Pathology (ITPA) as a resident and started her work for Compath. In February 2017, she passed the European College of Veterinary Pathologists Board Exam and worked in the diagnostic service.
In June 2017, Kerstin Hahn joined the “Cancer Therapy Resistance”- research group of Prof. S. Rottenberg as a postdoctoral research fellow. Her current research focuses on residual disease in human BRCA-deficient breast and ovarian cancer using classical and organoid 3D cell culture systems as well as murine models.